Improved pharmacokinetic and cholecystokinin-2 receptor (CCK2R) targeting for diagnosis and treatment

摘要

The present invention provides peptidomimetics useful for therapeutic and diagnostic purposes as well as compositions, methods, uses and kits based on the peptidomimetic. In particular, the peptidomimetics of the invention are introduced by CCK2R expressing cells, such as cancer cells. This makes it possible, for example, to selectively destroy cancer cells or to selectively image cancer cells expressing CCK2R.